Back to results
US 5,478,929 AGranted
Bioconversion products of 27-hydroxy avermectin
AssigneeMerck & Co., Inc.
InventorsByron H. Arison, Patrick J. Doherty, Marvin D. Schulman
Life of this patent
Estimating the term…
Abstract
There are disclosed novel compounds which are derived from 22,23-dihydro avermectin B1 aglycone. The compounds are both isomers of the 27-hydroxy adduct of the substrate avermectin compound that have been glycosylated at the 4" position to yield 4"-O-glucosyl 27-OH avermectin compounds. The compounds and the intermediates used to make them are highly potent antiparasitic, insecticidal and anthelmintic avermectin agents.
Claims3
A compound represented by Compound II or III:
- ##STR4## wherein the hydroxyl ground at the 27-position represents the A and B isomers.
Dependencies are inferred from the claim text.